Research Chemical Designation & Liability
Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.
Ipamorelin
Growth Hormone Secretagogues
Molecular Dossier
- Rank Index: 9
- Status: FDA Category 1
- What does this mean?
- Molecular Structure: Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys)
About Ipamorelin
Selective ghrelin receptor agonist that stimulates GH release without cortisol spikes.
Clinical Focus
Growth Hormone / Sleep Quality
Archival Aliases
Ipa, The Selective GHRP
Frequently Asked Questions
What are the strict legal and safety limitations for research-grade peptides?
All products listed in this research database are intended solely for laboratory research purposes and are not for human or animal consumption, diagnostic, or therapeutic use. As a researcher, it is your responsibility to ensure that all experimental protocols comply with local and federal regulations. These compounds are provided in lyophilized form to maintain chemical stability and must be handled by qualified professionals in a controlled environment. Any use outside of a supervised laboratory setting is strictly prohibited and violates the intended research application of these materials.
What are the potential risks of improper peptide handling in a research environment?
Improper handling of peptides can lead to rapid degradation, loss of potency, or chemical contamination. Exposure to high temperatures, direct sunlight, or physical agitation (shaking the vial) can break the delicate peptide bonds, rendering the research sample useless for data collection. Furthermore, using non-sterile solvents or failing to maintain a cold chain during transport can introduce bacterial pathogens. Researchers must prioritize aseptic techniques and precise reconstituting protocols to ensure the integrity of the experimental results and the longevity of the research material.
What makes ipamorelin unique among GHRPs?
Ipamorelin is the most selective growth hormone releasing peptide (GHRP) available. Unlike GHRP-2 and GHRP-6, it does not significantly elevate cortisol, prolactin, or ACTH at research doses. This selectivity means the GH pulse it generates mimics the body's natural pulsatile release more closely, without the cortisol-driven catabolism or appetite increase seen with less selective GHRPs.
How does ipamorelin stimulate growth hormone release?
Ipamorelin acts as an agonist at the ghrelin receptor (GHSR-1a) in the pituitary gland. Binding triggers a signaling cascade that results in pulsatile GH secretion. It works synergistically with GHRH analogs like CJC-1295 by acting on a different receptor — CJC-1295 increases GH pulse amplitude while ipamorelin increases pulse frequency, making the combination significantly more effective than either compound alone.
What are the sleep and recovery benefits of ipamorelin?
Ipamorelin's GH-stimulating effects are time-sensitive. When administered 30-60 minutes before sleep, it amplifies the natural GH surge that occurs during slow-wave (deep) sleep. Elevated nocturnal GH promotes cellular repair, protein synthesis, and fat oxidation during sleep. Research subjects report improvements in sleep quality and morning recovery, consistent with GH's role in sleep architecture.
What is the half-life of ipamorelin and how often should it be administered?
Ipamorelin has a short half-life of approximately 2 hours. Because it mimics pulsatile GH release, it is most effective when administered 2-3 times daily, with the most important dose being pre-sleep. Continuous elevation of ipamorelin is not desirable — the body's pituitary requires recovery periods between pulses to maintain receptor sensitivity.
Does ipamorelin cause water retention or puffiness?
Compared to synthetic GH injections, ipamorelin produces significantly less water retention. This is because it works within the body's natural feedback loops, producing more physiological GH levels rather than supraphysiological ones. Water retention is most common when ipamorelin is combined with high-dose GHRH analogs and at very high doses.
How does ipamorelin compare to direct growth hormone injections?
Direct GH injections bypass pituitary function and can suppress endogenous GH production over time through negative feedback. Ipamorelin works through the pituitary, preserving the natural secretory mechanism. It produces lower peak GH levels than exogenous GH, but maintains the pulsatile pattern and physiological feedback loops. The cost and regulatory risk are also substantially lower.
Is ipamorelin safe for long-term research use?
Ipamorelin has one of the strongest safety profiles among research peptides based on animal data. It does not significantly affect cortisol or appetite-stimulating hormones, making it less disruptive to metabolic function. There are no published long-term human studies, so optimal cycle length and long-term effects remain unstudied. Periodic breaks are generally recommended to maintain pituitary sensitivity.
What are the best stacks that include ipamorelin?
The two most studied ipamorelin combinations are: (1) CJC-1295 + Ipamorelin — the classic GH optimization stack for body recomposition and sleep quality; and (2) Tesamorelin + Ipamorelin — the "Visceral Shred" protocol, clinically validated for reducing visceral adipose tissue. Ipamorelin is also included in comprehensive protocols like The God Protocol alongside metabolic peptides.
Clinical Data Matrix
| Parameter | Clinical Value |
|---|---|
| Molecular Weight | Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys) |
| Primary Pathway | Growth Hormone Secretagogues |
| Research Phase | FDA Category 1 |
Clinical Pros
- Highly selective receptor modulation
- Documented efficacy in Phase II trials
- Minimal systemic cross-reactivity
Research Limitations
- Limited long-term human data
- Strict storage and reconstitution requirements
- Potential for acute homeostatic feedback loops
Community Discussion
Share your questions and experiences with other researchers in the forum.
Discuss in ForumClinical Reference Nodes
Data Verified: 2026-05-07